A new report shows that the number of FDA approvals for cancer drugs has shot up in the last few decades. What’s behind the rise?
Revised GMP guidelines will strengthen emphasis on contamination control, impacting cleanroom performance qualifications
FDA looks to improve transparency and predictability for generic drug applicants
How those in the outsourcing sector can be more prepared to meet shifting customer demands as the industry continues to evolve.